
    
      To treat an intermediate size patient population of bilateral lung transplant patients with
      CLAD-0. Treating physicians will follow standard of care for patients and monitor pulmonary
      function, fractional exhaled nitric oxide and quality of life of the patients.

      Patient safety will be monitored by assessing changes in these parameters, as well as changes
      in standard of care measurements (e.g., laboratory values and x-ray images).
    
  